IP Library Granted Patent US 7,148,264
Granted Patent B2
US 7,148,264 · App. 10/915,290 · Granted Dec 12, 2006

Method of producing macroporous cross-linked polymer particles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,148,264
App. No.
10/915,290
Granted
Dec 12, 2006
Kind
B2
Abstract

The present invention relates to a method of producing one or more macroporous cross-linked polymer particles, which comprises polymerization and cross-linking of divinyl ether monomers in an inert solvent, in which method the polymerization is free radical initiated. The invention also relates to particles so produced, which are useful as separation medium e.g. in RPC or, after suitable derivatization, in other chromatographic methods.

Claims (6)

1. A method of producing one or more macroporous cross-linked polymer particles, which comprises polymerisation and cross-linking of a monomer mixture consisting of divinyl ether monomers in an inert solvent, wherein the polymerisation is free radical initiated and the divinyl ether monomers are defined by the chemical formula (II)

C═C—O—R—O—C═C  (II)

wherein R can be any group that does not interfere chemically or sterically with the polymerization; and wherein the divinyl ether monomers are selected from the group consisting of cyclohexanedimethanol divinyl ether, butanediol divinyl ether and diethyleneglycol divinyl ether.

2. The method of claim 1 , wherein R is selected from cyclohexanedimethylene groups.

3. The method of claim 1 , wherein said polymerisation is a suspension polymerisation.

4. The method of claim 1 , further comprising modifying the surface of the particles produced by derivatisation of residual vinyl groups.

Assignments (4)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2004
From: SODERMAN, TOBIAS; LARSSON, ANDERS; BUSSON, PHILIPPE
To: AMERSHAM BIOSCIENCES AB
Reel/Frame 015298/0383 →